HempNewsBreaks

MondayJul 01, 2024 3:35 pm

HempNewsBreaks – Golden Triangle Ventures Inc.’s (GTVH) Lavish Moves to Become Staple in the Entertainment Industry

Golden Triangle Ventures’ (OTC: GTVH) Lavish Entertainment embodies GTVH’s focus on vertical integration to cut costs and maximize margins, as evidenced by its recently released four-pillar business model. “According to GTVH, this strategic framework provides an essential piece of Lavish’s mission to create an industry leading entertainment business. The company’s new model includes key foundational elements – logistics, staffing, equipment and production – that were carefully identified and organized to complement each other and ensure seamless operations across all facets of the company. With its new business model as a backdrop, Lavish Entertainment plans to develop and acquire operations in…

Continue Reading

ThursdayJun 27, 2024 3:30 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review board approval for its GLP-1 human pilot study #2, seeking to explore the oral delivery of GLP-1 drugs. For Lexaria, this marks a significant milestone that brings it closer to offering a more effective and…

Continue Reading

ThursdayJun 20, 2024 12:21 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Announces Significant Progress on Destino Ranch Project

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today provided an update on its premier project, Destino Ranch, which is being developed by the company’s entertainment division through its wholly owned subsidiary, Lavish Entertainment. Destino Ranch is a bold project led by Lavish, designed to provide a unique combination of world-class entertainment, opulent accommodations and immersive experiences. Lavish has made significant progress in developing Destino Ranch over the past six months, including a massive overhaul of the irrigation system and extensive cleanup efforts including the repair of perimeter fencing, reinstallation of gates, and opening of roadways around the project. Tree care has…

Continue Reading

TuesdayJun 18, 2024 2:17 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Engages CRO for DehydraTECH GLP-1 Human Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced it has hired a contract research organization (“CRO”) to oversee execution of the company’s 12-week chronic study GLP-1-H24-4. The study will evaluate various DehydraTECH-GLP-1 (glucagon-like peptide) formulations and other treatments with efficacy objectives of weight loss, blood sugar reduction and more. “This study will be the most comprehensive and impactful GLP-1 investigation that Lexaria has ever undertaken,” said John Docherty, president of Lexaria. “The greatly expanded scope compared to our previous studies will allow us to investigate DehydraTECH-GLP-1 safety and efficacy over an extended treatment duration…

Continue Reading

FridayJun 14, 2024 1:23 pm

HempNewsBreaks – Astrotech Corp. (NASDAQ: ASTC) Subsidiary Partners with Multistate Testing Lab to Market Proprietary AgLAB Solutions

Astrotech (NASDAQ: ASTC), an innovative science and technology company, and its subsidiary, AgLAB, have entered into a master lease agreement with SC Labs; the companies are working together to jointly market the AgLAB 1000-D2(TM) mass spectrometer and the AgLAB Maximum Value Process testing method to SC Labs customers. AgLAB has pioneered applications featuring the Astrotech Mass Spectrometer Technology that specifically target the hemp and cannabis markets while SC Labs, one of the largest multistate cannabis and hemp-testing labs in the United States, delivers industry-leading, science-based innovations in cannabis and hemp testing. The partnership between the two entities extends SC Labs’ analytical services directly…

Continue Reading

FridayJun 14, 2024 10:59 am

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Receives Full Financial Commitment to Move Forward with Launch of Freight Brokerage Division

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has received the financial commitment required to launch an internal, full-service freight-brokerage business designed to significantly expand its logistics capabilities. GTVH made this announcement following the completed acquisition of Cargo Management Group from TK Zarro LLC; the acquisition includes a logistics operation, brokerage business, licenses and all associated assets. The announcement noted that the company received full financial support from TK Zarro to obtain state-of-the-art freight brokerage software, Transportation Management System (TMS), and load board subscriptions to streamline operations and improve service delivery. The announcement also stated that the transition will…

Continue Reading

TuesdayJun 11, 2024 1:14 pm

HempNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation at Upcoming Emerging Growth Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates, will be featured in this week’s Emerging Growth Conference. The conference is slated for June 12–13, 2024. According to the announcement, InMed Pharmaceuticals CEO Eric A. Adams will be presenting at the two-day event. During his presentation, Adams will provide a corporate overview of the company; the presentation will also include a Q&A session. Adams’ presentation is scheduled to begin at 1:45 p.m. EDT on June 13. An archived replay of the presentation will be available on the InMed Pharmaceuticals website.…

Continue Reading

ThursdayJun 06, 2024 1:57 pm

HempNewsBreaks – Golden Triangle Ventures Inc. (GTVH) Completes Cargo Management Group Acquisition, Focuses on Long-Term Shareholder Value

Golden Triangle Ventures (OTC: GTVH), a multifaceted consulting company, has completed the acquisition of Cargo Management Group, a multifaceted logistics and trucking operation. According to the announcement, the transaction involved using 10% of the profits from GTVH’s logistics business to buy back and retire GTVH stock, which effectively reduced the number of outstanding shares on a consistent basis as profits are realized. This move represents Golden Triangle Ventures focus on driving long-term value for its shareholders. The company noted that Cargo Management Group reported nearly $3 million in revenue for 2023; the acquisition is expected to streamline internal operations, yield…

Continue Reading

WednesdayJun 05, 2024 3:07 pm

HempNewsBreaks – Alternative Products Expo Returns to Texas for Flagship Global Counterculture Event

Alternative Products Expo (Alt Pro Expo) is preparing to kick off its next in a series of blowout events across North and South America. Presented by ZJ Evets, Alt Pro Expo is slated for June 20–22, 2024, in Houston, Texas. Through the years, Alt Pro Expo has built a reputation for creating a flagship series of events in the global counterculture industry. The agenda for the networking festival includes invaluable education while the exhibit area spotlights an incredible portfolio of innovative products, including vape and hemp products, CBD, disposables, kratom, mushrooms, functional beverages, dietary supplements, nootropics, nicotine replacement, energy enhancers, mood…

Continue Reading

WednesdayJun 05, 2024 2:50 pm

HempNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Completion of Dosing in Second Arm of Third GLP-1 Human Pilot Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, is reporting that the second round of dosing for all nine study participants in the second arm of its human pilot study #2 has been completed. The company anticipates completion of the final arm of the study, GLP-1-H24-2, in July. A three-arm, crossover investigation that compares three 7 mg semaglutide dose formulations, the study evaluates three doses: a positive control Rybelsus(R) swallowed tablet; DehydraTECH-semaglutide swallowed capsule; and for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. The study is designed to measure tolerability and side effects as well…

Continue Reading